Doral Healthcare Finance (DHF) today announced it has provided an amended credit facility for an existing client with an increase in commitment to $15.0 million to a company that provides specialty closed-door pharmacy services primarily related to hemophiliacs and IVIG therapies in Philadelphia, New York and Chicago.

“Doral Healthcare Finance is pleased to support the growth of our existing client base as we continue to actively lend within the healthcare industry. The expanded facility will assist our client in managing their growth objectives,” said Jennifer Sheasgreen, DHF managing director.

Doral Healthcare Finance (“DHF”) is a division of Doral Money, Inc. engaged in providing an asset-based lending, working capital lines of credit to providers of goods and services in the healthcare industry nationwide, including hospitals, home healthcare agencies and long-term care facilities with financing needs from one million to $20 million.